Cargando…

Inflammatory reactions mimic residual or recurrent lymphoma on [(18)F]FDG-PET/CT after CD19-directed CAR T-cell therapy

Detalles Bibliográficos
Autores principales:	de Boer, Janneke W., Pennings, Elise R. A., Kleinjan, Ankie, van Doesum, Jaap A., Spanjaart, Anne M., Mutsaers, Pim G. N. J., Jak, Margot, van der Poel, Marjolein W. M., Kuipers, Maria T., Adam, Judit A., Diepstra, Arjan, Koens, Lianne, van Dorp, Suzanne, Vermaat, Joost S. P., Niezink, Anne G. H., Kersten, Marie José, van Meerten, Tom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641469/ https://www.ncbi.nlm.nih.gov/pubmed/37639324 http://dx.doi.org/10.1182/bloodadvances.2023010665

Ejemplares similares

Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related Toxicities
por: de Boer, Janneke W., et al.
Publicado: (2023)

Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities
por: Spanjaart, Anne M., et al.
Publicado: (2023)

The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The Netherlands
por: Spanjaart, Anne M., et al.
Publicado: (2023)

P1462: POPULATION-BASED REAL WORLD RESULTS OF CD19-DIRECTED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: A DUTCH CAR T-CELL TUMORBOARD EXPERIENCE
por: Spanjaart, A. M., et al.
Publicado: (2022)

Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: Diagnosis and Treatment
por: van Doesum, Jaap A., et al.
Publicado: (2021)

P1128: EVALUATION OF STANDARD OF CARE IN SECOND-LINE FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE PRE-CAR-T ERA: A DUTCH POPULATION-BASED STUDY
por: Pennings, Elise R.A., et al.
Publicado: (2023)

Semi-automated (18)F-FDG PET segmentation methods for tumor volume determination in Non-Hodgkin lymphoma patients: a literature review, implementation and multi-threshold evaluation
por: Keijzer, Kylie, et al.
Publicado: (2023)

Disc‐like lesions in the intestinal tract after renal transplantation
por: Kwakernaak, Arjan J., et al.
Publicado: (2022)

High frequency of hyperglycaemia observed during CAR T‐cell treatment
por: Tienstra, Marieke, et al.
Publicado: (2022)

Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach
por: de Groot, Fleur A., et al.
Publicado: (2022)

Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma
por: Langendonk, Myra, et al.
Publicado: (2022)

P1411: FIRST EVALUATION OF A MOBILE HEALTH APP DEVELOPED TO MONITOR ACUTE TOXICITIES AFTER CAR T-CELL THERAPY: A THINK ALOUD STUDY WITH PATIENT EXPERTS
por: Kos, Milan, et al.
Publicado: (2023)

A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipients
por: Gard, Lilli, et al.
Publicado: (2017)

Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort study
por: Brink, Mirian, et al.
Publicado: (2022)

Non‐small‐cell lung cancer infiltrated with chronic myelomonocytic leukaemia: a molecular diagnostic challenge to recognise mixed cancers in a single biopsy
por: Koopman, Bart, et al.
Publicado: (2021)

Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands
por: van Doesum, Jaap, et al.
Publicado: (2020)

Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma
por: Nijland, Marcel, et al.
Publicado: (2018)

Interim thymus and activation regulated chemokine versus interim (18)F‐fluorodeoxyglucose positron‐emission tomography in classical Hodgkin lymphoma response evaluation
por: Plattel, Wouter J., et al.
Publicado: (2020)

Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach
por: de Jong, Mathilde R. W., et al.
Publicado: (2018)

R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma
por: Al-Sarayfi, Diana, et al.
Publicado: (2022)

Tumour necrosis as assessed with (18)F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
por: Kahle, Xaver U., et al.
Publicado: (2019)

Additional antibody suppression from rituximab added to conventional therapy in severe, refractory anti-GBM nephritis
por: Mutsaers, Pim, et al.
Publicado: (2010)

Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA
por: Veltmaat, Nick, et al.
Publicado: (2023)

Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas
por: Schrader, Anne M. R., et al.
Publicado: (2022)

For Better or for Worse: COVID-19 Vaccination during or Early after (Immuno-) Chemotherapy or Hematopoietic Progenitor Cell Transplantation
por: Haggenburg, Sabine, et al.
Publicado: (2021)

P1209: INCIDENCE, TREATMENT AND OUTCOME OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA: A POPULATION-BASED COHORT STUDY IN THE NETHERLANDS
por: Meeuwes, F. O., et al.
Publicado: (2022)

Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients
por: Rutgers, Abraham, et al.
Publicado: (2022)

CD57+ T-cells are a subpopulation of T-follicular helper cells in nodular lymphocyte predominant Hodgkin lymphoma
por: Sattarzadeh, Ahmad, et al.
Publicado: (2015)

Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma
por: Visser, Lydia, et al.
Publicado: (2016)

Erratum: Lydia Visser et al. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma, Int. J. Mol. Sci. 2016, 17, 2127
por: Sattarzadeh, Ahmad, et al.
Publicado: (2018)

A population-based study of transformed marginal zone lymphoma: identifying outcome-related characteristics
por: Bult, Johanna A. A., et al.
Publicado: (2023)

Feasibility of the PalliSupport care pathway: results from a mixed-method study in acutely hospitalized older patients at the end of life
por: Flierman, Isabelle, et al.
Publicado: (2020)

The Impact of Rectal Stump Inflammation After Subtotal Colectomy on Pouch Outcomes in Ulcerative Colitis Patients
por: Wasmann, Karin A, et al.
Publicado: (2020)

The prevalence of stress‐related outcomes and occupational well‐being among emergency nurses in the Netherlands and the role of job factors: A regression tree analysis
por: de Wijn, Anne Nathal, et al.
Publicado: (2021)

Insulin-Like Growth Factor 1 Receptor Is a Prognostic Factor in Classical Hodgkin Lymphoma
por: Liang, Zheng, et al.
Publicado: (2014)

Toll-like receptors in the pathogenesis of human B cell malignancies
por: Isaza-Correa, Johana M, et al.
Publicado: (2014)

The Microenvironment in Epstein–Barr Virus-Associated Malignancies
por: Tan, Geok Wee, et al.
Publicado: (2018)

Relationship between semiquantitative (18)F-fluorodeoxyglucose positron emission tomography metrics and necrosis in classical Hodgkin lymphoma
por: Kahle, X. U., et al.
Publicado: (2019)

Tertiary lymphoid structures are confined to patients presenting with unifocal Langerhans Cell Histiocytosis
por: Quispel, Willemijn T., et al.
Publicado: (2016)

Clinicopathological characteristics of T-cell non-Hodgkin lymphoma arising in patients with immunodeficiencies: a single-center case series of 25 patients and a review of the literature
por: Nijland, Marieke L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lmca6gb2k7h243m0ag3b335pq9